Medical/Pharmaceuticals
KPJ Healthcare Sets Southeast Asian Record in Robotic Cardiac Surgery
Damansara Specialist Hospital 2 achieves regional first with 35 robotic-assisted minimally invasive cardiac surgery cases in 90 days KUALA LUMPUR, Malaysia, Oct. 30, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") has set a Southeast Asian record in robotic-assisted ...
2026-10-30 14:41
4738
Phrontline Biopharma Highlights Encouraging Preliminary Safety and Antitumor Activity of TJ101 Presented at ESMO 2026 and Announces Phase Ib Initiation
Preliminary responses observed in 6 of 8 evaluable urothelial carcinoma patients (75%), including patients previously treated with enfortumab vedotin and pembrolizumab Early antitumor activity also observed in squamous NSCLC, SCLC and prostate cancer SHANGHAI and HANGZHOU, China, Oct. 29, 2026 ...
2026-10-30 09:00
4589
Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering
BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing next-generation, long-acting precisionbispecific antibodies for immunology and inflammation, today announced the pricing of ...
2026-10-30 08:15
6994
Haier Biomedical Brings Blood Management and Pharmaceutical Cold Storage Expertise to AABB and ISPE 2026
ATLANTA and NATIONAL HARBOR, Md., Oct. 29, 2026 /PRNewswire/ -- Haier Biomedical
2026-10-29 21:50
5177
OncoC4 Announces Oral Presentation of a Late-Breaking Abstract on Cesalatamig at the 41st Annual Meeting of SITC
— Global Phase 1/2 Study Data in PD-(L)1–Resistant/Refractory NSCLC to Be Presented on November 7, 2026 — — Clinical Oral Abstract Session 2 Begins at 1:45 PM MST — ROCKVILLE, Md., Oct. 29, 2026 /PRNewswire/ -- OncoC4 Inc., a late clinical-stage biopharmaceutical company developing novel medicin...
2026-10-29 21:30
6126
Yuyu Pharma Explores Animal Health as a New Pathway for Human Drug Innovation
SEOUL, South Korea, Oct. 29, 2026 /PRNewswire/ -- Yuyu Pharma (KRX: 000220) CEO Robert Wonsang Yu shared the company's vision for connecting human and animal health at BIOPLUS-INTERPHEX KOREA 2026 (BIX 2026), highlighting how pharmaceutical research and development can create new opportunities ac...
2026-10-29 21:00
3775
United Imaging Healthcare Reports 19.43% Revenue Growth in First Nine Months of 2026, with Cumulative R&D Investment Exceeding RMB 10 Billion Since 2022
SHANGHAI, Oct. 29, 2026 /PRNewswire/ -- United Imaging Healthcare (688271.SH), a global innovator in advanced medical imaging technologies and intelligent healthcare solutions, reported revenue of RMB 10.58 billion for the first nine months of 2026, up 19.43% year-on-year. Sustained investment in...
2026-10-29 15:32
4212
SGH's AI tool wins international award for improving antibiotic use
SINGAPORE, Oct. 29, 2026 /PRNewswire/ -- Singapore General Hospital (SGH) has won the Silver Award in the Dr Prathap C Reddy Excellence Award for Clinical Quality and Patient Safety at the International Hospital Federation (IHF) Awards 2026, for its Augmented Intelligence in Infectious Diseases (...
2026-10-29 14:00
4129
Total Investment of Approx. USD 6.8 Million in Product Development for Malaria, NTDs and Other Emerging & Re-emerging Infectious Diseases Such as Ebola Disease
TOKYO, Oct. 29, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.06 billion (USD 6.8 million1) in nine R&D projects for the development of drugs, vaccines and diagnostics for malaria, neglected tropical diseases (NT...
2026-10-29 10:00
3514
Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted HbA1c Reduction of 1.7% at 12 Weeks from Its U.S. Phase II Study in Participants with Diabetes
- ASC30 reduced HbA1c by a placebo-adjusted 1.7%, 1.6% and 1.7% from baseline for 40 mg, 60 mg and 80 mg, respectively, at 12 weeks, the primary endpoint. - ASC30 achieved placebo-adjusted weight reduction of 4.4%, 3.8% and 4.0% from baseline for 40 mg, 60 mg and 80 mg, respectively and no platea...
2026-10-29 07:40
3994
IFPA: World Psoriasis Day 2026, Young people speak up against stigma and discrimination
STOCKHOLM, Oct. 28, 2026 /PRNewswire/ -- More than 100 million people worldwide live with psoriasis and psoriatic arthritis, and one in three develop first symptoms before age of 20. This World Psoriasis Day, October 29, IFPA (the International Federation of Psoriasis Associations) is launching a...
2026-10-28 19:30
2226
IMDA and NUH Partner in First Open Innovation Platform Collaboration in Public Healthcare
Partnership accelerates healthcare innovation by connecting real-world hospital needs with technology expertise SINGAPORE, Oct. 28, 2026 /PRNewswire/ -- The Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH), through its Kent Ridge Office of Innovation (KROI),...
2026-10-28 17:04
2582
Ozelle to Spotlight Scalable AI-Assisted Hematology with O-Cyte 1 at MEDICA 2026
O-Cyte 1 combines CBC testing and reviewable cell images with expandable throughput and service-ready design. DÜSSELDORF, Germany, Oct. 28, 2026 /PRNewswire/ -- As AI-assisted morphology becomes more integrated into routine hematology, laboratories need more than automated cell classification. C...
2026-10-28 16:15
2613
CELSET Launches SOLTOX, a Korean Botulinum Toxin Type A Brand, for International Markets
SEOUL, South Korea, Oct. 28, 2026 /PRNewswire/ -- CELSET INC., a Korean
biotechnology company specializing in medical aesthetics, has launched SOLTOX,
its botulinum toxin type A brand, introducing a Korean botulinum toxin brand to
the international medical aesthetics industry.
2026-10-28 16:00
2912
Jiahui Launches International Cell Therapy Center to Expand Global Access to CAR-T Treatment
SHANGHAI, Oct. 28, 2026 /PRNewswire/ -- Jiahui International Hospital launched Jiahui International Cell Therapy Center, building on landmark CAR-T cases and multidisciplinary expertise to serve patients from China and abroad. The center was unveiled at the inaugural Jiahui International Cell The...
2026-10-28 14:41
2457
The Jumbophage Cocktail_Fighting Superbugs and Shrimp Disease
BANGKOK, Oct. 28, 2026 /PRNewswire/ -- What if a weapon against some of the world's most stubborn bacteria were hiding in the soil beneath our feet? Could these microscopic hunters help us confront antibiotic-resistant "superbugs" and bacterial diseases devastating shrimp? The answer may lie in u...
2026-10-28 14:24
3712
Docquity Extends Asian Healthcare Intelligence to the Middle East Through Strategic Partnership with Growth Partner Holding
Saudi Arabia launch opens the region, with expansion planned into Egypt, Turkey, Jordan and Iraq; Ask Dx is the core platform RIYADH, Saudi Arabia and SINGAPORE, Oct. 28, 2026 /PRNewswire/ -- Docquity, the clinical AI platform for more than 500,000 verified doctors across Asia, today announced a...
2026-10-28 13:40
3926
From China to the Global Stage: Hengrui Showcases Innovative Research at ESMO Congress 2026, Exploring New Approaches to Oncology Treatment
Record 64 Research Presentations Highlight Hengrui's Oncology R&D Strength and Growing International Reach MADRID and SHANGHAI, Oct. 27, 2026 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) Congress 2026 recently concluded in Madrid. As a leading innovator in China's pharmaceuti...
2026-10-28 11:32
3946
Lynk Pharmaceuticals Reports Positive Long-Term Phase III Results for Zemprocitinib in bDMARDs-Inadequate Responders with Moderate-to-Severe Rheumatoid Arthritis
HANGZHOU, China, SHANGHAI and BOSTON, Oct. 28, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced positive long-term results from its pivotal Phase III clin...
2026-10-28 08:00
4440
Fosun Health Makes Historic Debut at Canton Fair, Foshan Fosun Chancheng Hospital Showcases International Healthcare Services
GUANGZHOU, China, Oct. 28, 2026 /PRNewswire/ -- Fosun Health has become the first cross-border international healthcare group to exhibit at the Canton Fair in its 70-year history, debuting at the event's inaugural International Healthcare Zone alongside four Greater Bay Area (GBA) hospitals, incl...
2026-10-28 08:00
5363
Week's Top Stories
Most Reposted
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1121 media titles]
2026-11-06 22:06
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
[Picked up by 1109 media titles]
2026-11-09 23:00
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
[Picked up by 1083 media titles]
2026-11-10 22:17
Most Read
Home Companion Robot Mobo to Debut Globally and Open Pre-orders as AiMOGA Showcases Its Robot Family at the 2026 OMODA & JAECOO International User Summit
2026-11-07 13:49
27121
ZD Energy Unveils Overseas Smart Energy Solutions in Thailand, Leveraging Local Manufacturing and Scenario-Based Capabilities to Support the Country's Energy Transition
2026-11-06 22:12
16027
SILVERSEA MARKS HISTORIC OPENING OF THE CORMORANT AT 55 SOUTH, THE SOUTHERNMOST HOTEL ON EARTH, OFFERING A NEW GATEWAY TO ANTARCTICA
2026-11-07 01:05
15464
Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
2026-11-06 22:06
12682